Instructor, Psychiatry and Psychology, Mayo Med Sch
Pathology
Dr. Min Shi, MD
|
|
Give Review
Doctor Min Shi, MD is an expert in the field of Pathology. He graduated from Beijing Medical University. has written publications. He has 20 publications published with PubMed. The lastest publication is: 'Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.' Min Shi is registered with Medicare and accepts Medicare payments.
Publications
- Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.
- CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease.
- Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ42 using Meso Scale Discovery Assays for Alzheimer's Disease.
- Observing implantable collamer lens dislocation by panoramic ultrasound biomicroscopy.
- Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery.
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.
- Targeted Discovery and Validation of Plasma Biomarkers of Parkinson's Disease.
- Proteomic Analysis of Saliva from Patients with Oral Chronic Graft-Versus-Host Disease.
- Thyroid lymphoma on a background of Hashimoto's thyroiditis: PET/CT appearances.
- Five important advances in hematopathology.
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson's Disease Progression in the DATATOP Cohort.
- Solitary plasmacytoma of the uvula.
- Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control.
- Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease.
- Improved Detection Rate of Cytogenetic Abnormalities in Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms With Use of CpG-Oligonucleotide DSP30 and Interl...
- ?-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
- Pulmonary papillary adenoma: a case report and review of the literature.
- Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma.
- Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Options PPO
Education
-
University of Massachusetts -
Beijing Medical University
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023242567 |
| Last Name Of The Provider | SHI |
| First Name Of The Provider | MIN |
| View All |
Similar Doctors
|
|
Dr. Kevin C. Halling, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Joseph P. Grande, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Denis M. Bonin, MD |
|
|
Dr. Cassie L. Booth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad M. Botz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pashtoon M. Kasi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Justin D. Kreuter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jamie L. Odem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann M. Moyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendy Rizzo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kanaka-Durga S. Vege, MD |